Comvita Limited (CVNZF) Fair Value & Analysis
Consumer Defensive · US · Market cap $32.5M
Fair value as of: Jun 25, 2026
Analysis
Comvita Limited (CVNZF) currently trades at $0.4161, while our model-based Fair Value estimate is $1.11 — implying the stock looks roughly 166.8% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through its website. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Comvita Limited (CVNZF) undervalued?
What is the fair value of CVNZF?
What is the quality score of CVNZF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.